Second Annual Midwest Metabolic Clinical Symposium - Session 7
About This Webcast
Michael Fuchs, M.D., Ph.D., FAASLD, AGAF, FEBGH Professor of Medicine, Virginia Commonwealth University, Richmond, Chief of Gastroenterology, Central Virginia VA Health Care System, Richmond, VISN 6 Lead Gastroenterologist, Vice-Chair, NAFLD FAB Subcommittee, Director of GI Research, Richmond Institute for Veterans Research (RIVR) Michael Trauner, M.D. Visiting Professor, Division of Gastroenterology & Hepatology, Saint Louis University Professor & Chair of Gastroenterology & Hepatology Medical University of Vienna, Department of Medicine III, Division of Gastroenterology & Hepatology Jonathan G. Stine, M.D., MSc, FACP Fatty Liver Program Director, Liver Center Director of Research, Penn State Health, Associate Professor of Medicine & Public Health Sciences, Division of Gastroenterology & Hepatology, Department of Medicine, Department of Public Health Sciences, Penn State Cancer Institute, Penn State Health- Milton S. Hershey Medical Center Michael Trauner, M.D. Visiting Professor, Division of Gastroenterology & Hepatology, Saint Louis University, Professor & Chair of Gastroenterology & Hepatology Medical University of Vienna, Department of Medicine III, Division of Gastroenterology & Hepatology
Speakers
Michael Fuchs, M.D., Ph.D., FAASLD, AGAF, FEBGH
Professor of Medicine , Virginia Commonwealth University
Michael Fuchs is a Fellow of the American Gastroenterological Association, American Association for the Study of Liver Diseases and the European Board of Gastroenterology and Hepatology. He earned his MD, PhD degree from the University of Ulm, Germany and where he completed his training in Internal Medicine and Gastroenterology. He completed a research fellowship at Brigham and Women’s Hospital/Harvard Digestive Diseases Center in Boston during that time. In 2006 he was recruited to the US and since then has served as a principal investigator for numerous industry-sponsored and investigator-initiated clinical trials, particularly in patients with viral hepatitis and steatotic liver disease. He is a member of the Liver Forum, Global Liver Institute and serves on several committees of the Veterans Health Administration. Over the last few years, Dr. Fuchs has developed one of the largest research programs within VA providing access to novel liver and gastrointestinal disease therapies and diagnostics. With his comprehensive leadership skills and interest in public health/healthcare delivery, Dr. Fuchs is involved in the design, development, restructuring and implementation of effective, seamless and sustainable integrated healthcare delivery systems for Veterans with steatotic liver disease. He is the VA lead gastroenterologist for VISN 6 and the upcoming Chair of VA’s Field Advisory Board MASLD Sub-committee.
Michael Trauner, M.D.
Visiting Professor, Professor & Chair of Gastroenterol , Medical University of Vienna, Department of Medicine III, Division of Gastroenterology & Hepatology
Michael Trauner, MD, received his medical education at the Karl-Franzens-University in Graz, Austria, where he started his residency and fellowship in internal medicine in 1991. From 1994 to 1997 he was trained as an Erwin Schrödinger postdoctoral research fellow of the Austrian Science Foundation at Yale University’s Department of Internal Medicine and Liver Center in New Haven, USA, where he worked on the molecular alterations of hepatobiliary transport systems in cholestasis in the lab of James L. Boyer. After returning to Graz, he completed his training in internal medicine and a fellowship in gastroenterology and hepatology. He then established an internationally recognized research group in cholestatic and fatty liver diseases, and founded the Liver Center at the Medical University of Graz, serving as professor of experimental and clinical hepatology. Since 2010 he has been professor of gastroenterology and hepatology and chair of the Division of Gastroenterology and Hepatology at the Medical University of Vienna, where he is also division head of one of the largest clinical gastroenterology, endoscopy, and liver services in Europe. Dr. Trauner’s main research interests are the molecular mechanisms of bile acid transport and signaling in cholestatic and steatotic liver diseases, the mechanisms of cell injury in cholestatic and steatotic liver disease, and the development of novel pharmacologic treatments for cholestatic and steatotic liver diseases. He has published more than 760 peer-reviewed scientific papers listed in Pubmed (H-index 101), 45 book chapters and has edited 3 books. He has delivered more than 250 invited lectures at international scientific meetings, mainly on molecular and clinical aspects of cholestatic and metabolic liver diseases, and holds three patents on the treatment of cholestatic and metabolic liver diseases.
Jonathan G. Stine, M.D., MSc, FACP
Fatty Liver Program Director, Liver Center Director of Research, Penn State Health, Associate Professor of Medicine , Penn State Cancer Institute, Penn State Health- Milton S. Hershey Medical Center
Dr. Jonathan Stine is an Associate Professor of Medicine and Public Health Science at Penn State. As an internationally recognized liver expert with a research and clinical focus on metabolic dysfunction-associated steatotic liver disease (MASLD) and exercise, he has authored more than 100 peer-reviewed papers, including multinational consensus guidelines. Stine is the recipient of multiple research grants and awards from the American Association for the Study of Liver Diseases, American Cancer Society and has maintained continuous funding from the National Institutes of Health since 2018. Dr. Stine is the MASLD consultant to the American College of Sports Medicine’s Exercise is Medicine initiative and recently co-chaired the International Roundtable on MASLD and Physical Activity for ACSM. Dr. Stine serves as the Fatty Liver Program Director as well as the Liver Center Research Director for Penn State.